Renal protection against ischaemia-reperfusion in transplantation

Completed

You are on the General Public view
  • Source

    -
    Public Title Renal protection against ischaemia-reperfusion in transplantation
    Acronym REPAIR
    Source of Record URL http://isrctn.org/ISRCTN30083294
  • Trial

    -
    Health Condition(s) or Problem Kidney transplantation
    Lay Summary Sorry, not currently available
    Who can enter the trial 1. Patients undergoing living donor transplantation 2. Patients aged 18 years and above, either sex
    Who cannot enter the trial 1. 0,0,0-mismatched renal grafts (no mismatch in HLA-A/B/DR antigens between donor and recipient) 2. Patients on adenosine triphosphate (ATP)-sensitive potassium channel opening or blocking drugs 3. Patients on ciclosporin 4. Patients who have had a previous transplant 5. Patients with a known iodine sensitivity (who cannot undergo iohexol clearance studies) Added 04/08/10 6. Patients with ABO incompatability 7. Any patient requiring HLA antibody removal therapy
    What will happen The trial will test whether a simple procedure, the application of a blood pressure cuff to the arm of the donor and the recipient before a kidney transplant, can help protect the donor kidney from the harmful effects of the transplant. The blood pressure cuff to be used is similar to the one that is used to measure blood pressure. It will be inflated continuously for a five-minute period, after which it will be deflated for 5 minutes. This cycle of inflation, followed by deflation, will be performed 4 times in total. The trial follow up is 5 years, performed in the context of routine clinical follow up.
    Primary aim Glomerular filtration rate (GFR) 12 months after transplantation.
    Secondary Aim 1. Rate of fall in creatinine in the first 72 hours after transplantation 2. Inflammatory response to surgery in the first 5 days after transplantation 3. Protein expression in kidney parenchyma samples using histochemistry 4. Protein activation and expression in renal vasculature using immunoblotting 5. Kidney fibrosis 6 months after transplantation 6. Alloreactivity of T-cells in the first 18 months after transplantation 7. Patient outcomes 2 - 5 years after transplantation using renal registry data
    Participant Information Sheet Not available in web format, please use the contact details below to request a patient information sheet
    Website Sorry, not currently available
    Recruitment Status Completed
    Nation England
    Location London
  • Contact

    -
    Contact for Public Queries Prof Raymond MacAllister BHF Laboratories 5 University Street London WC1E 6JJ United Kingdom r.macallister@ucl.ac.uk
    Contact for Scientific Queries Sorry, not currently available
Please note:
  1. The UKCTG information is designed to inform you of existing trials. If you wish to join a specific trial, you must discuss this with your own doctor who may decide to get in touch with the contact listed.
  2. The UKCTG is not responsible for the quality of the data displayed in the Gateway but can contact the data providers. Please contact us if you have any query regarding the quality of trial records.